Evaluation of the risk factors of radio-dermatitis after breast-conserving surgery

Evaluation of the risk factors of radio-dermatitis after breast-conserving surgery | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research article Evaluation of the risk factors of radio-dermatitis after breast-conserving surgery Xin PENG, YI REN, Qin HE, Lijuan XIONG This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-15417/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background The morbidity of breast cancer has been ranked first among female cancers worldwide and increased by 2% each year in these ten years [1]. Although China as a country with a relatively low incidence of breast cancer compares to other countries, the rapid growth rate of breast cancer is still worth noticing [2]. Method A total of 521 patients with breast cancer diagnosed in the Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology and underwent breast conserving surgery (lumpectomy plus local radiotherapy) were selected, to investigate demographic data, disease data, treatment data and behavior data. Using univariate and multivariate logistic regression method to analyze the risk factors of RD after radiotherapy. Results The variable factors of age ≤40 years old, whiter skin, treatment time in summer, BMI≥25, local thermal therapy, sun exposure, skin scratching and bra wearing are the risk factors of radio-dermatitis, while the affected limb akimbo in daytime and elevating the affected limb in sleep are the protective factors of radio-dermatitis. Conclusion This study aims to observe the situation of post-radiotherapy RD after breast-conserving surgery in patients with breast cancer, analyze the risk factors related to patients and treatment, and provide the relevant clinical basis for reducing and preventing the occurrence of RD after breast-conserving surgery. Cancer Biology Oncology Breast cancer post-breast-conserving surgery radiotherapy risk factors of radio-dermatitis (RD) 1. Introduction At present, except a small number of advanced breast cancer is still using the traditional radical or extended radical surgery, improved surgery such as breast-conserving surgery has been the major surgery treatment of breast cancer in China. On the other hand, radiotherapy as one of the indispensable treatment methods for breast cancer, which can eliminate the subclinical carcinogenesis, and local recurrence can be significantly reduced by adding radiation therapy after breast-conserving surgery. In the course of radiotherapy, while inhibiting or killing the tumour cells, it also has some adverse impact on body tissues, thus causing different levels of radiation damage to normal tissues. It can cause both local and systemic reactions, among which the most common is skin damage, namely radiodermatitis (RD), manifested as varying degrees of erythema, dry, wet peeling, ulcers and other skin damage [3] . Patients with severe RD usually need to suspend radiotherapy and wait for skin repair, which causes the patient to suffer and also causes certain economic losses [4] . Therefore, to find out the risk factors and their corresponding prevention of RD has always been the particular concern of the medical care personnel. Breast conserving surgery is suitable for T1, T2 and partial T3 stages of breast cancer. Nevertheless, due to the limitation of Chinese national conditions, the proportion of breast conserving surgery in China is far from in United States, France and other western countries [5] . With the enhancement of early diagnosis, the development of comprehensive systemic treatment, popularity of technology and advanced radiotherapy equipment, and the improvement of post-operative quality of life for breast cancer patients, laid the foundation for breast conserving surgery that make it to be the inevitable trend of breast cancer [6] . On the other hand, radiotherapy as one of the indispensable treatment methods for breast cancer, which can eliminate the subclinical carcinogenesis. Local recurrence can be significantly reduced by adding radiation therapy after breast conserving surgery. In addition, as the development of conformal strength modulation technology, the radiation dose is more reasonable, and the chest radiation injury has significantly reduced. Thus, the radiation therapy is as a routine treatment nowadays [7] . In terms of RD is an adverse cutaneous reaction that occurs during or after radiotherapy or interventional radiology. There are two major factors that affect RD, which are internal factors (patient’s own factors affecting wound healing) and external factors (radiation dose, energy and segmentation method). Due to the external factors are controllable, however, the internal factors are determined by the combination of immutable innate genetic factors and intervening acquired personal factors [8] . Thus, based on the theoretical basis above, this study divides these two factors into three parts. Firstly, radiation factors, including radiation dose, energy, location, and so on; Secondly, genetic factors, including gender, size of breast, co-existing radiosensitive diseases, cancer susceptibility family, hereditary cancer, family history of cancer, and so on. Thirdly, personal factors, including age, and with basic diseases, such as diabetes, chemotherapy, nutrition level, smoking, infection, UV exposure, etc. 2. Method From January 2018 to December 2019, a total of 521 patients with breast cancer diagnosed in the Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology and underwent breast conserving surgery (lumpectomy plus local radiotherapy) were selected, to investigate demographic data, disease data, treatment data and behavior data. Using univariate and multivariate logistic regression method to analyze the risk factors of RD after radiotherapy. 2.1 Radiotherapy 2.1.1 Patients with fixed The patient lies supine on a special breast bracket. According to the bodily form of the patient to determine the position of head pillow, the surface of breast bracket inclination, the fixed location of upper limbs and hips, let the affected side of chest wall at a horizontal level, and make sure the upper arm is fully raised. 2.2.2 CT simulation orientation Determining the laser alignment point on the patient body surface. Spiral CT was used to scan the calm breathing state, and the scanning layer was 5mm. The scan covers the entire mammary gland and extents at least 3mm away from the upper and lower boundary, where including all the adjacent tissues and organs, such as bilateral lungs and breasts, heart, and so on. The CT images were obtained and transmitted over a private network to the 3D radiotherapy planning system (3D-TPS). 2.2.3 Target area delineation and definition The CT simulated positioning image with 3D-TPS will be transferred for 3D reconstruction. The affected breast is the clinical target volume (CTV). The upper boundary is the level of the thoracic entrance or the lower margin of the clavicle head, the lower boundary is 2cm below the breast fold; While the inner boundary is the ipsilateral sternocostal joint, and the outer boundary is the midaxillary line or the posterior axillary line; The anterior boundary is 5mm below the thoracic epidermis, and the posterior boundary is close to the chest wall. The planned target volume (PTV) is obtained by extending 5mm of the CVT. 2.2.4 Treatment plan design Intensity modulated radiotherapy (IMRT) plan was designed by using 3D-TPS, IMRT was beneficial to evenly distribute the radiation dose in the breast target area, that effectively reduce the skin damage level during radiotherapy [9] . The radiation source is 6mv-X-ray, and 5–7 coplanar conformal fields were set, to optimize the bed angle, frame angle and each field dose weight. Using MLC to form 25–40 subfields for distribution irradiation. The prescription dose for whole breast is 50Gy/25times. Then 8mv-E electron wire is used to supplement the tumor bed with 10Gy daily, 5 days a week. 2.2.5 Use of skin compensation film on the chest wall In this study, 0.5–1cm thick compensation film was used to increase the skin dose of chest wall when the radiotherapy treatment dose of enrolled patients reached 0–36Gy. 3. Evaluation Tool The first time of skin observation of this study was the 30 days after the start of the radiotherapy, and the changes of chest wall were not recorded after 300 days. The second observation end point was when the patient’s skin symptoms were first assessed as radioactive dermatitis. The severity of radiodermatitis was determined on the basis of the clinical manifestations of grade 1–3 radiodermatitis which were defined in the Common terminology criteria for adverse events (CTCAE) version 4.0, which has been designed by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), to evaluate the severity of organ or tissue toxicity or damage for patients receiving cancer therapy [10] . Before radiotherapy, the patients were informed with the information about potential skin damage during the radiotherapy by their attending physician, and to be asked to report the skin changes in a timely manner without self-treatment. Skin changes were evaluated by an experienced nursing care team at least once a week. 3.1 Statistical approach Statistic package for social science (SPSS) 24.0 software was used for statistical analysis. The incidence of radiodermatitis is calculated by Kaplan-Meier method. Kaplan-Meier method is used to estimate the survival function from lifetime data. In medical research, it frequently be used to measure the fraction of patients living for a certain duration of time after a certain treatment [11] . Risk factors of radiodermatitis after radiotherapy are analyze by stepwise logistic regression with single and multiple factors. P < 0.05 is considered as statistically significant. 3.2 Results 3.2.1 Results: Clinical characteristics of patients These results include all the 521 patients who had completed radiotherapy and skin compensation membrane (See table 1). The results showed that there were statistically significant differences between the two groups in age, BMI, skin type, season, local hyperthermia, sun exposure, skin scratching, bra wearing, limb akimbo during the day, and limb elevation during sleep (P0.05). 3.2.2 Results: Incidence and occurrence time of radiodermatitis In this study, the incidence of radiodermatitis after radiotherapy in breast cancer patients undergoing breast conserving surgery was 10.39%. The severity was mainly second degree that at a proportion of 76.11%, and the median time of occurrence was within two weeks after the end of radiotherapy (See table 2). The dependent variable was radiodermatitis, and the independent variables were age, BMI, skin type, summer, local hyperthermia, sun exposure, skin scratching, bra wearing, akimbo the affected limb in the daytime and elevation of the affected limb while sleeping. Logistic regression analysis has performed as in table 2. The regression results in the table 3 has shown that the age, skin type, the affected limb akimbo in daytime and elevation of limb while sleeping had a negative effect on the presence or absence of radiodermatitis (P0.05). Through the results, it suggested that the variable factors of age ≤40 years old, whiter skin, treatment time in summer, BMI≥25, local thermal therapy, sun exposure, skin scratching and bra wearing are the risk factors of radiodermatitis, while the affected limb akimbo in daytime and elevating the affected limb in sleep are the protective factors of radiodermatitis (see table 3). 4. Discussion In this retrospective study, relevant data were collected to evaluate the incidence and risk factors of radiodermatitis after radiotherapy after breast conserving surgery in female breast cancer patients. Reasonable study design was adopted to collect and evaluate patients’ symptoms every week during and after radiotherapy, so as to ensure timely and accurate data collection and objectivity. However, the main defect of this study is that the data comes from a single medical center, which may affect the results of the factor analysis and lead to biased results. Among the factors that affect radiodermatitis, clinical radiologists paying more attention on radiation factors than genetic factors, as the genetic factors are harder to intervene than the radiation factors. In nursing aspect, by contrast, the part that allows for early intervention is the individual factors. At present, the empirical data of individual factors are very limited, but they are the most concerned and interested part of clinical radiology nurses. In the risk factors which related to radiodermatitis, the study controlled for radiotherapy factor related variables, by focusing on individual variables such as individual factors and genetic factors related to the partial treatment, and combining relevant literature, to expend corresponding nursing measures. Under normal circumstance, the skin is in a continuous process of metabolism, the surface cells shed, the basal cells divide and multiply, migrate toward epidermis, keratinization. However, radiotherapy can lead to irreversible double-strand breaks in DNA of basal keratinocytes, stem cells in the hair follicles and increased melanocytes production. The migration of immune cells such as leukocytes to from circulation toward to irradiated skin area is the significant hallmark of radiodermatitis. Thereafter, the death of epidermal cells, biochemical changes in endothelia cells and DNA destruction, as well as inflammatory reactions that can cause skin damage [12] . In the existing studies on risk factors of radiodermatitis, empirical evidence shows that age, skin characteristics, nutritional status, basic diseases, race, smoking, genetic factors, radiation dose, concurrent chemotherapy and irradiation site are closely related to radiodermatitis [13] . In this study, according to logistic regression analysis that age below 35 years, fair skin, treatment time in summer, BMI above 25, local thermotherapy, sun exposure, hot water bath, skin scratch and bra wearing were risk factors for radiodermatitis in patients. The protected factors of the affected limb were akimbo in day time and elevation of the affected limb before bedtime (P<0.05, P<0.01). Body weight/ BMI/ smoking/ diabetes Body weight, BMI, smoking, diabetes which are metabolic diseases are different from some foreign studies in multivariate analysis of patient own factors, which did not exclude the limitations caused by monocentric study and ethnic differences. According to Beamer (2019) [14] , body weight and BMI can be seen as an evaluative parameter to predict the degree of radiodermatitis, as the data has shown that more dermatitis responses in heavier patients than in lighter patients, whilst age and height had no effect on radiodermatitis. In this study, we obey the BMI standard which seen BMI>25 as overweight and BMI>30 as obese, while the results have been showed that in the radiodermatitis group in table 1, there are 55 out of 57 of patients whose BMI ≥25; This means BMI significantly can be a risk factor of developing radiodermatitis. Furthermore, Marinello et al. (2016) [15] noted that smoking history has been included as a risk factor for radiodermatitis, as smoking aggravates the microcirculation abnormality that caused by radiotherapy. Due to the low proportion of smoking history in the enrolled patients in this study, they were not included in the study scope. Further relevant studies are needed to determine whether metabolic abnormalities such as obesity and diabetes that affect the repair mechanism of radiological damage to the skin. Adjuvant radiotherapy Adjuvant radiotherapy after breast conserving radical surgery can reduce the local recurrence rate of breast cancer, among which patients with high risk factors that need adjuvant chemotherapy to improve their survival rate. Although radiotherapy combined with adjuvant chemotherapy can exacerbate adverse reactions, but generally for most patients with good tolerability, postoperative radiotherapy and adjuvant chemotherapy are safe and feasible. Radiotherapy combined with adjuvant chemotherapy also demonstrated improved rates of breast conservation and reduced risk of locoregional recurrence, which are safe and feasible [16] . In this study, the factor of concurrent chemotherapy was taken into consideration to analyze whether it aggravates the incidence of radiodermatitis. Patient age ≤ 40 years Age ≤ 40 years for the viewpoint that the prognosis of young women with breast cancer is worse than that of elderly women, relevant western studies define the range of young women as ≤ 40 years, while the Chinese domestic literatures classified the age as ≤ 40 years as well [17–18] . In terms of this study, age ≤ 40 years was considered as one of the risk factors for the occurrence of radiodermatitis, and statistical analysis was conducted. Skin color and sun exposure The grating characteristics of Chinese women’s skin color were evaluated in this study. The effect of X-ray radiation on the skin during radiotherapy depends on how sensitive the skin towards to the radiation [19] . Considering that the principle of the action of rays on the skin is similar to the reaction of the skin caused by solar irradiation, this study suggests that the sunlight reaction can be related to dermatitis reaction of patients. In this study, the skin color of patients was evaluated and the degree of sunlight exposure of patients to their skin color and daily activities were also evaluated. From level 1 (always exposure to the sun, rarely tanned) to level 4 (rarely exposure to the sun, but easily tanned), in order to reflect the sensitivity of the patients to radiation, and thus to infer the possibility of radiodermatitis. According to the study of Yamazaki et al. (2011) [20] , skin pigmentation of patients after radiotherapy was predicted by skin color changes that caused by sun exposure; This study believed that the degree of sun exposure and skin color of patients could be used as criteria to judge whether patients were at high risk of radiodermatitis. Treatment time When the treatment time is summer, the climate is hot and humid, the capillary diastole and the blood circulation is rich. Increased sensitivity of vascular endothelia cell to the radiation, coupled with more local skin sweating, thus increase the chance of wet dermatitis. There are few research data and references in this filed. Combined with the experience of a large number of clinical nurses, it is considered that the admission time of patients with radiodermatitis is concentrated in summer. Therefore, the correlation between seasonal factors and the incidence of radiodermatitis was statistically analyzed. Local thermal therapy Local thermal therapy is an advanced and effective method to treat tumor. The clinical trial has shown that the combination of thermal therapy and radiotherapy can significantly improve the local control rate of tumors and the survival rate of patients [21] . Lilla et al. (2007) [22] reported that the radiotherapy circumstance of 416 cases of breast cancer patients after breast conserving surgery, and analyzed the significant relationship between radioactive dermatitis and telangiectasia, this allowed for local hyperthermia to cause telangiectasia at the site of radiotherapy. At the same time, combined with relevant studies and analysis, it was found that although adverse reactions to thermal therapy were relatively mild, it can still cause blisters, subcutaneous indentation, subcutaneous pain, and even more serious skin damage such as radiodermatitis [23] . Therefore, local thermal therapy was included in this study. A hot bath/ scratching the skin/ Wearing a bra/ exposure to the sun After the patients with a diagnosis of breast cancer have had radiotherapy, the skin tissue where has been accepted radiation became thinner than before, particularly prone to skin reactions. Relevant evidence-based nursing studies show that in order to reduce reaction after radiotherapy, relevant skin care measures include: 1) Educating patients to wear cotton underwear to avoid skin friction in and around the radiotherapy area. 2) Local soap scrubbing or hot water bath and sun exposure are prohibited to avoid skin irritation in the radiotherapy area. 3) When the skin in the radiotherapy area is itchy and unbearable, gently pat the local skin with their hand, cannot scratch the skin [24] . Although such nursing education is conducted by nurses to patients in daily clinical care, the effects of activities such as hot baths, scratching of skin, wearing of bras and exposure to the sun on radiodermatitis are still discussed and analyzed in consideration of the differences in patient compliance. 5. Conclusion This retrospective study is based on the observation and statistics of the relevant clinical characteristics and incidence of chest wall radiodermatitis of 521 female breast cancer patients treated with radiotherapy after breast conserving surgery. It was found that age ≤ 40 years, fair skin, treatment time is in summer, BMI ≥ 25, local hyperthermia, sun exposure, hot water bath, skin scratching and bra wearing significantly increased the risk of radiodermatitis. Given the impact of radiodermatitis, especially grade 2 to 3 radiodermatitis, on permanent damage to the skin, the nursing team needs to carefully assess the patient’s risk factors before and after radiotherapy, and carry out targeted nursing for high-risk groups, to reduce the incidence of radiodermatitis, improve the quality of life of patients, maintain the beauty of breast after breast-conserving treatment, and reduce the psychological pressure of patients. Declarations Ethical approval This study has been approved by the Ethics Committee of Drug Clinical Trials of Huazhong University of Science and Technology; It has been carried out in the city of Wuhan, where located in the middle south of China, with the registration number 1900022422. The participants who have been involved in this study has signed the informed consent form before being included in the study. Consent for publication Not applicable. Availability of data and materials The data be used and analyzed during the current study are available from the corresponding authors on reasonable request. Competing interests The authors declare that they have no competing interests. Funding The role of 2018 textbook construction project of Huazhong University of Science and Technology in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript that gave much support. The reference number is 02.05.18020018. Authors contributions PENG Xin, female, master, supervisor nurse, head nurse, Hubei anti-cancer association breast cancer professional committee vice chairman, teacher of Nursing Department of Tongji Medical College, Hubei province pain demonstration ward evaluation expert, Chinese journal of nursing manuscript reviewer; Department of Breast Oncology, Wuhan Union Medical College Hospital, Wuhan, China. Email: [email protected] , Mobile phone: 15071399933, ORCID number: 0000 0002 8061 2335. She initiated and conceived this research article with her nursing team, and collect data from the ward of breast cancer oncology. She also did supervision, suggestion and involved in the original article writing. Co-first author - REN Yi, female, Chinese registered nurse; former registered nurse of Department of integrated Chinese and western medicine, Wuhan Union Medical College Hospital, Wuhan, China; Currently as a Senior nursing student in Wintec institute of science and technology, Hamilton, New Zealand. Email: [email protected] , Mobile phone: 022 6852603, ORCID number: 0000 0003 0872 9915. She cooperated with the nursing team, help them with problem solving and given advice with the article. She also involved in translating the Chinese version to English version, and find relevant resources to support the project. Corresponding author: HE Qin, female, master, head nurse, teacher of Nursing Department of Tongji Medical College, Hubei province pain demonstration ward evaluation expert; Public Health Department, Wuhan Union Medical College Hospital, Wuhan. Email: [email protected] . She has been involved in the clinical supervision and the article review. XIONG Lijuan, female, master, supervisor nurse, head nurse, teacher of Nursing Department of Tongji Medical College, Hubei province pain demonstration ward evaluation expert, Chinese journal of nursing manuscript reviewer; Nursing Department, Wuhan Union Medical College Hospital, Wuhan. Email: [email protected] . She has been involved in the clinical supervision and the article review. References Secginli S, Nahcivan N O, Gunes G, et al. Interventions promoting breast cancer screening among Turkish women with global implications: a systematic review[J]. Worldviews on Evidence‐Based Nursing, 2017, 14(4): 316-323. Tang Y, Mao W, Tang S. Primary and secondary prevention of breast cancer in China: a scoping review[J]. The Lancet, 2019, 394: S76. Alexopoulou E, Katsila T, Tolia M, et al. An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients[J]. Anticancer research, 2018, 38(3): 1615-1622. Kole A J, Kole L, Moran M S. Acute radiation dermatitis in breast cancer patients: challenges and solutions[J]. Breast Cancer: Targets and Therapy, 2017, 9: 313. Zhang J. 235P Study on the socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women breast cancer[J]. Annals of Oncology, 2019, 30(Supplement_5): mdz240. 059. Yao R, Pan B, Xu Y, et al. Abstract P2-14-30: Survival outcomes of breast conserving surgery versus mastectomy for ultrasound detected non-palpable breast cancer in hospital-based screening among Chinese women[J]. 2019. Chollet-Hinton L, Anders C K, Tse C K, et al. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study[J]. Breast Cancer Research, 2016, 18(1): 79. Robijns J, Laubach H J. Acute and chronic radiodermatitis: clinical signs, pathophysiology, risk factors and management options[J]. Journal of the Egyptian Women's Dermatologic Society, 2018, 15(1): 2-9. Pignol J P, Truong P, Rakovitch E, et al. Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial[J]. Radiotherapy and oncology, 2016, 121(3): 414-419. Kitajima M, Mikami K, Noto Y, et al. Quantitative assessment of radiodermatitis through a non‑invasive objective procedure in patients with breast cancer[J]. Molecular and Clinical Oncology, 2019, 12(1): 89-93. Lacny S, Wilson T, Clement F, et al. Kaplan–Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis[J]. Journal of clinical epidemiology, 2018, 93: 25-35. Karbasforooshan H, Hosseini S, Elyasi S, et al. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double‐blind, placebo‐controlled clinical trial[J]. Phytotherapy research, 2019, 33(2): 379-386. Borm K J, Loos M, Oechsner M, et al. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer-the impact of dose distribution and patient related factors[J]. Radiation Oncology, 2018, 13(1): 218. Beamer L C. Novel measurements for radiodermatitis research and clinical care: a pilot and feasibility study[J]. European Journal of Oncology Nursing, 2019, 39: 62-69. Marinello E, Causin F, Brumana M B, et al. Radiodermatitis after spinal arteriovenous fistula embolisation[J]. BMJ case reports, 2016, 2016: bcr2016214384. Garg A K, Buchholz T A. Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer[J]. Annals of surgical oncology, 2015, 22(5): 1434-1440. Coles C E, Griffin C L, Kirby A M, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicenter, randomized, controlled, phase 3, non-inferiority trial[J]. The Lancet, 2017, 390(10099): 1048-1060. Liem G S, Mo F K F, Pang E, et al. Chemotherapy-related amenorrhea and menopause in young Chinese breast cancer patients: analysis on incidence, risk factors and serum hormone profiles[J]. PloS one, 2015, 10(10): e0140842. Wolf J R, Ling M. Radiation dermatitis [J]. Web link: https://www.uptodate.com/contents/radiation-dermatitis , 2018, 11060596. Samanta S, Rice S R, Siddiqui O M, et al. Concurrent External Thermal Therapy and Pencil Beam Scanning Proton Therapy or Photon/Electron Therapy for Recurrent Breast Cancer: Early Outcomes and Toxicity[J]. International Journal of Radiation Oncology• Biology• Physics, 2019, 105(1): E45-E46. Abadeer N S, Murphy C J. Recent progress in cancer thermal therapy using gold nanoparticles[J]. The Journal of Physical Chemistry C, 2016, 120(9): 4691-4716. Beamer L C, Grant M. Using the Dermatology Life Quality Index to Assess How Breast Radiodermatitis Affects Patients’ Quality of Life[J]. Breast cancer: basic and clinical research, 2019, 13: 1178223419835547. Tables Table 1 The difference comparison between the two groups of influencing factors [n (%)] factors Non-radiodermatitis group (n=464) Dermatitis group (n=57) x 2 /Z P 8.994 ※ 0.003 Age ≤40 228(49.1) 40(70.2) >40 236(50.9) 17(29.8) Hypertension 0.204 ※ 0.651 none 459(98.9) 56(98.2) yes 5(1.1) 1(1.8) Diabetes 0.109 ※ 0.741 none 444(95.7) 54(94.7) yes 20(4.3) 3(5.3) BMI(Kg/m 2 ) 8.649 ※ 0.003 <25 89(19.2) 2(3.5) ≥25 375(80.8) 55(96.5) T stage 0.040 ※ 0.842 stage1-2 275(59.3) 33(57.9) stage3-4 189(40.7) 24(42.1) Grade -0.209 △ 0.834 Grade 1 30(6.5) 4(7.0) Grade 2 382(82.3) 47(82.5) Grade 3 52(11.2) 6(10.5) Occurrence time -0.347 △ 0.729 4周 60(12.9) 9(15.8) Adjuvant chemotherapy 0.104 ※ 0.747 no 47(10.1) 5(8.8) yes 417(89.9) 52(91.2) Skin type -3.928 △ <0.01 I 13(2.8) 12(21.1) II 241(51.9) 31(54.4) III 176(37.9) 10(17.5) IV 27(5.8) 3(5.3) V 7(1.5) 1(1.8) Season 13.08 ※ 0.004 Spring 92(19.8) 11(19.3) Summer 147(31.7) 31(54.4) Autumn 150(32.3) 10(17.5) Winter 75(16.2) 5(8.8) Local thermal-therapy 9.788 ※ 0.002 no 232(50.0) 16(28.1) yes 232(50.0) 41(71.9) Sun exposure 9.250 ※ 0.002 no 420(90.5) 44(77.2) yes 44(9.5) 13(22.8) Skin scratching 11.25 ※ 0.001 no 438(94.4) 47(82.5) yes 26(5.6) 10(17.5) Bra dressing 10.68 ※ 0.001 no 418(90.1) 43(75.4) yes 46(9.9) 14(24.6) Akimbo the affected limb in the day time 4.182 ※ 0.041 no 382(82.3) 53(93.0) yes 82(17.7) 4(7.0) Raise the affected limb while sleeping 6.218 ※ 0.013 no 346(74.6) 51(89.5) yes 118(25.4) 6(10.5) Note: ※ The statistic x 2 value of the chi-square test， △ The statistic Z value of the rank sum test. Table 2 The evaluation of variables Variable Value assignment Dependent variable Radiodermatitis 0=no；1=yes Independent variable Age (year) 1=≤40；2=>40 BMI 1=<25Kg/m 2 ；2=≥25Kg/m 2 Skin type 1= type I；2= type II；3= type III；4= type IV；5= type V Summer 0=no；1=yes Local thermal therapy 0=no；1=yes Sun exposure 0=no；1=yes Skin scratching 0=no；1=yes Bra dressing 0=no；1=yes Akimbo of the affected limb in the daytime 0=no；1=yes Elevation of the affected limb while sleeping 0=no；1=yes Table 3 Logistic regression analysis of the influence of different factors on radiodermatitis Factors Regression coefficient Standard error Wald P OR 95CI Lower limit Upper limit age -0.730 0.332 4.826 0.028 0.482 0.251 0.924 BMI 1.838 0.749 6.017 0.014 6.281 1.447 27.273 Skin type -0.728 0.249 8.565 0.003 0.483 0.297 0.786 Summer 1.019 0.323 9.973 0.002 2.772 1.472 5.218 Local thermal therapy 0.973 0.341 8.145 0.004 2.645 1.356 5.158 Sun exposure 1.022 0.414 6.077 0.014 2.778 1.233 6.259 Skin scratching 0.962 0.469 4.210 0.040 2.618 1.044 6.566 Bra dressing 1.144 0.418 7.481 0.006 3.140 1.383 7.128 Akimbo the affected limb in the daytime -1.292 0.580 4.963 0.026 0.275 0.088 0.856 Elevating the affected limb while sleeping -0.998 0.484 4.241 0.039 0.369 0.143 0.953 Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-15417","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research article","associatedPublications":[],"authors":[{"id":374735,"identity":"e929088b-e89b-48a2-89a0-f1c04908cf48","order_by":1,"name":"Xin PENG","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0003-0872-9915","institution":"Wuhan Union Hospital","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Xin","middleName":"","lastName":"PENG","suffix":""},{"id":374736,"identity":"6da46656-90b1-40c0-9230-fcfde436e74f","order_by":2,"name":"YI REN","email":"","orcid":"","institution":"Waikato Institute of Technology","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"YI","middleName":"","lastName":"REN","suffix":""},{"id":374737,"identity":"0e26eb35-75ae-43d0-993d-03134b40aa0b","order_by":3,"name":"Qin HE","email":"","orcid":"","institution":"Wuhan Union Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Qin","middleName":"","lastName":"HE","suffix":""},{"id":374738,"identity":"7bb6c0ea-ebe4-4356-8553-c42804f428d8","order_by":4,"name":"Lijuan XIONG","email":"","orcid":"","institution":"Wuhan Union Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Lijuan","middleName":"","lastName":"XIONG","suffix":""}],"badges":[],"createdAt":"2020-02-26 15:47:45","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-15417/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-15417/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":13491063,"identity":"2e6062ca-c6d0-471f-990a-af605a11426c","added_by":"auto","created_at":"2021-09-16 22:26:07","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":335337,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-15417/v1/47ef9d37-2aea-4b13-98c1-062f52fa86dd.pdf"}],"financialInterests":"","formattedTitle":"Evaluation of the risk factors of radio-dermatitis after breast-conserving surgery","fulltext":[{"header":"1. Introduction","content":"\u003cp\u003eAt present, except a small number of advanced breast cancer is still using the traditional radical or extended radical surgery, improved surgery such as breast-conserving surgery has been the major surgery treatment of breast cancer in China. On the other hand, radiotherapy as one of the indispensable treatment methods for breast cancer, which can eliminate the subclinical carcinogenesis, and local recurrence can be significantly reduced by adding radiation therapy after breast-conserving surgery. In the course of radiotherapy, while inhibiting or killing the tumour cells, it also has some adverse impact on body tissues, thus causing different levels of radiation damage to normal tissues. It can cause both local and systemic reactions, among which the most common is skin damage, namely radiodermatitis (RD), manifested as varying degrees of erythema, dry, wet peeling, ulcers and other skin damage \u003csup\u003e[3]\u003c/sup\u003e. Patients with severe RD usually need to suspend radiotherapy and wait for skin repair, which causes the patient to suffer and also causes certain economic losses \u003csup\u003e[4]\u003c/sup\u003e. Therefore, to find out the risk factors and their corresponding prevention of RD has always been the particular concern of the medical care personnel.\u003c/p\u003e\n\n\u003cp\u003eBreast conserving surgery is suitable for T1, T2 and partial T3 stages of breast cancer. Nevertheless, due to the limitation of Chinese national conditions, the proportion of breast conserving surgery in China is far from in United States, France and other western countries \u003csup\u003e[5]\u003c/sup\u003e. With the enhancement of early diagnosis, the development of comprehensive systemic treatment, popularity of technology and advanced radiotherapy equipment, and the improvement of post-operative quality of life for breast cancer patients, laid the foundation for breast conserving surgery that make it to be the inevitable trend of breast cancer \u003csup\u003e[6]\u003c/sup\u003e. On the other hand, radiotherapy as one of the indispensable treatment methods for breast cancer, which can eliminate the subclinical carcinogenesis. Local recurrence can be significantly reduced by adding radiation therapy after breast conserving surgery. In addition, as the development of conformal strength modulation technology, the radiation dose is more reasonable, and the chest radiation injury has significantly reduced. Thus, the radiation therapy is as a routine treatment nowadays \u003csup\u003e[7]\u003c/sup\u003e.\u003c/p\u003e\n\n\u003cp\u003eIn terms of RD is an adverse cutaneous reaction that occurs during or after radiotherapy or interventional radiology. There are two major factors that affect RD, which are internal factors (patient’s own factors affecting wound healing) and external factors (radiation dose, energy and segmentation method). Due to the external factors are controllable, however, the internal factors are determined by the combination of immutable innate genetic factors and intervening acquired personal factors \u003csup\u003e[8]\u003c/sup\u003e. Thus, based on the theoretical basis above, this study divides these two factors into three parts. Firstly, radiation factors, including radiation dose, energy, location, and so on; Secondly, genetic factors, including gender, size of breast, co-existing radiosensitive diseases, cancer susceptibility family, hereditary cancer, family history of cancer, and so on. Thirdly, personal factors, including age, and with basic diseases, such as diabetes, chemotherapy, nutrition level, smoking, infection, UV exposure, etc.\u003c/p\u003e\n"},{"header":"2. Method","content":"\u003cp\u003eFrom January 2018 to December 2019, a total of 521 patients with breast cancer diagnosed in the Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology and underwent breast conserving surgery (lumpectomy plus local radiotherapy) were selected, to investigate demographic data, disease data, treatment data and behavior data. Using univariate and multivariate logistic regression method to analyze the risk factors of RD after radiotherapy.\u003c/p\u003e\n\n\u003ch2\u003e2.1 Radiotherapy\u003c/h2\u003e\n\u003ch2\u003e2.1.1 Patients with fixed\u003c/h2\u003e\n\u003cp\u003eThe patient lies supine on a special breast bracket. According to the bodily form of the patient to determine the position of head pillow, the surface of breast bracket inclination, the fixed location of upper limbs and hips, let the affected side of chest wall at a horizontal level, and make sure the upper arm is fully raised.\u003c/p\u003e\n\n\u003ch2\u003e2.2.2 CT simulation orientation\u003c/h2\u003e\n\u003cp\u003eDetermining the laser alignment point on the patient body surface. Spiral CT was used to scan the calm breathing state, and the scanning layer was 5mm. The scan covers the entire mammary gland and extents at least 3mm away from the upper and lower boundary, where including all the adjacent tissues and organs, such as bilateral lungs and breasts, heart, and so on. The CT images were obtained and transmitted over a private network to the 3D radiotherapy planning system (3D-TPS).\u003c/p\u003e\n\n\u003ch2\u003e2.2.3 Target area delineation and definition\u003c/h2\u003e\n\u003cp\u003eThe CT simulated positioning image with 3D-TPS will be transferred for 3D reconstruction. The affected breast is the clinical target volume (CTV). The upper boundary is the level of the thoracic entrance or the lower margin of the clavicle head, the lower boundary is 2cm below the breast fold; While the inner boundary is the ipsilateral sternocostal joint, and the outer boundary is the midaxillary line or the posterior axillary line; The anterior boundary is 5mm below the thoracic epidermis, and the posterior boundary is close to the chest wall. The planned target volume (PTV) is obtained by extending 5mm of the CVT.\u003c/p\u003e\n\n\u003ch2\u003e2.2.4 Treatment plan design\u003c/h2\u003e\n\u003cp\u003eIntensity modulated radiotherapy (IMRT) plan was designed by using 3D-TPS, IMRT was beneficial to evenly distribute the radiation dose in the breast target area, that effectively reduce the skin damage level during radiotherapy \u003csup\u003e[9]\u003c/sup\u003e. The radiation source is 6mv-X-ray, and 5–7 coplanar conformal fields were set, to optimize the bed angle, frame angle and each field dose weight. Using MLC to form 25–40 subfields for distribution irradiation. The prescription dose for whole breast is 50Gy/25times. Then 8mv-E electron wire is used to supplement the tumor bed with 10Gy daily, 5 days a week.\u003c/p\u003e\n\n\u003ch2\u003e2.2.5 Use of skin compensation film on the chest wall\u003c/h2\u003e\n\u003cp\u003eIn this study, 0.5–1cm thick compensation film was used to increase the skin dose of chest wall when the radiotherapy treatment dose of enrolled patients reached 0–36Gy.\u003c/p\u003e\n"},{"header":"3. Evaluation Tool","content":"\u003cp\u003eThe first time of skin observation of this study was the 30 days after the start of the radiotherapy, and the changes of chest wall were not recorded after 300 days. The second observation end point was when the patient’s skin symptoms were first assessed as radioactive dermatitis. The severity of radiodermatitis was determined on the basis of the clinical manifestations of grade 1–3 radiodermatitis which were defined in the Common terminology criteria for adverse events (CTCAE) version 4.0, which has been designed by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), to evaluate the severity of organ or tissue toxicity or damage for patients receiving cancer therapy \u003csup\u003e[10]\u003c/sup\u003e. Before radiotherapy, the patients were informed with the information about potential skin damage during the radiotherapy by their attending physician, and to be asked to report the skin changes in a timely manner without self-treatment. Skin changes were evaluated by an experienced nursing care team at least once a week.\u003c/p\u003e\n\n\u003ch2\u003e3.1 Statistical approach\u003c/h2\u003e\n\u003cp\u003eStatistic package for social science (SPSS) 24.0 software was used for statistical analysis. The incidence of radiodermatitis is calculated by Kaplan-Meier method. Kaplan-Meier method is used to estimate the survival function from lifetime data. In medical research, it frequently be used to measure the fraction of patients living for a certain duration of time after a certain treatment \u003csup\u003e[11]\u003c/sup\u003e. Risk factors of radiodermatitis after radiotherapy are analyze by stepwise logistic regression with single and multiple factors. P \u0026lt; 0.05 is considered as statistically significant.\u003c/p\u003e\n\n\u003ch2\u003e3.2 Results\u003c/h2\u003e\n\u003ch2\u003e3.2.1 Results: Clinical characteristics of patients\u003c/h2\u003e\n\u003cp\u003eThese results include all the 521 patients who had completed radiotherapy and skin compensation membrane (See table 1). The results showed that there were statistically significant differences between the two groups in age, BMI, skin type, season, local hyperthermia, sun exposure, skin scratching, bra wearing, limb akimbo during the day, and limb elevation during sleep (P\u0026lt;0.05). However, there were no significant differences in the factors which include hypertension, diabetes, T stage, grade, occurrence time and adjuvant chemotherapy between the two groups (P\u0026gt;0.05).\u003c/p\u003e\n\n\u003ch2\u003e3.2.2 Results: Incidence and occurrence time of radiodermatitis\u003c/h2\u003e\n\u003cp\u003eIn this study, the incidence of radiodermatitis after radiotherapy in breast cancer patients undergoing breast conserving surgery was 10.39%. The severity was mainly second degree that at a proportion of 76.11%, and the median time of occurrence was within two weeks after the end of radiotherapy (See table 2). The dependent variable was radiodermatitis, and the independent variables were age, BMI, skin type, summer, local hyperthermia, sun exposure, skin scratching, bra wearing, akimbo the affected limb in the daytime and elevation of the affected limb while sleeping. Logistic regression analysis has performed as in table 2.\u003c/p\u003e\n\n\u003cp\u003eThe regression results in the table 3 has shown that the age, skin type, the affected limb akimbo in daytime and elevation of limb while sleeping had a negative effect on the presence or absence of radiodermatitis (P\u0026lt;0.05). On the other hand, the variable factors of BMI, summer, local hyperthermia, sun exposure, skin scratching and bra wearing had positive effects on the presence or absence of radiodermatitis (P\u0026gt;0.05). Through the results, it suggested that the variable factors of age ≤40 years old, whiter skin, treatment time in summer, BMI≥25, local thermal therapy, sun exposure, skin scratching and bra wearing are the risk factors of radiodermatitis, while the affected limb akimbo in daytime and elevating the affected limb in sleep are the protective factors of radiodermatitis (see table 3).\u003c/p\u003e"},{"header":"4. Discussion","content":"\u003cp\u003eIn this retrospective study, relevant data were collected to evaluate the incidence and risk factors of radiodermatitis after radiotherapy after breast conserving surgery in female breast cancer patients. Reasonable study design was adopted to collect and evaluate patients’ symptoms every week during and after radiotherapy, so as to ensure timely and accurate data collection and objectivity. However, the main defect of this study is that the data comes from a single medical center, which may affect the results of the factor analysis and lead to biased results.\u003c/p\u003e\n\n\u003cp\u003eAmong the factors that affect radiodermatitis, clinical radiologists paying more attention on radiation factors than genetic factors, as the genetic factors are harder to intervene than the radiation factors. In nursing aspect, by contrast, the part that allows for early intervention is the individual factors. At present, the empirical data of individual factors are very limited, but they are the most concerned and interested part of clinical radiology nurses. In the risk factors which related to radiodermatitis, the study controlled for radiotherapy factor related variables, by focusing on individual variables such as individual factors and genetic factors related to the partial treatment, and combining relevant literature, to expend corresponding nursing measures.\u003c/p\u003e\n\n\u003cp\u003eUnder normal circumstance, the skin is in a continuous process of metabolism, the surface cells shed, the basal cells divide and multiply, migrate toward epidermis, keratinization. However, radiotherapy can lead to irreversible double-strand breaks in DNA of basal keratinocytes, stem cells in the hair follicles and increased melanocytes production. The migration of immune cells such as leukocytes to from circulation toward to irradiated skin area is the significant hallmark of radiodermatitis. Thereafter, the death of epidermal cells, biochemical changes in endothelia cells and DNA destruction, as well as inflammatory reactions that can cause skin damage \u003csup\u003e[12]\u003c/sup\u003e.\u003c/p\u003e\n\n\u003cp\u003eIn the existing studies on risk factors of radiodermatitis, empirical evidence shows that age, skin characteristics, nutritional status, basic diseases, race, smoking, genetic factors, radiation dose, concurrent chemotherapy and irradiation site are closely related to radiodermatitis \u003csup\u003e[13]\u003c/sup\u003e. In this study, according to logistic regression analysis that age below 35 years, fair skin, treatment time in summer, BMI above 25, local thermotherapy, sun exposure, hot water bath, skin scratch and bra wearing were risk factors for radiodermatitis in patients. The protected factors of the affected limb were akimbo in day time and elevation of the affected limb before bedtime (P\u0026lt;0.05, P\u0026lt;0.01).\u003c/p\u003e\n\n\u003ch2\u003eBody weight/ BMI/ smoking/ diabetes\u003c/h2\u003e\n\u003cp\u003eBody weight, BMI, smoking, diabetes which are metabolic diseases are different from some foreign studies in multivariate analysis of patient own factors, which did not exclude the limitations caused by monocentric study and ethnic differences. According to Beamer (2019) \u003csup\u003e[14]\u003c/sup\u003e, body weight and BMI can be seen as an evaluative parameter to predict the degree of radiodermatitis, as the data has shown that more dermatitis responses in heavier patients than in lighter patients, whilst age and height had no effect on radiodermatitis. In this study, we obey the BMI standard which seen BMI\u0026gt;25 as overweight and BMI\u0026gt;30 as obese, while the results have been showed that in the radiodermatitis group in table 1, there are 55 out of 57 of patients whose BMI ≥25; This means BMI significantly can be a risk factor of developing radiodermatitis.\u003c/p\u003e\n\n\u003cp\u003eFurthermore, Marinello et al. (2016) \u003csup\u003e[15]\u003c/sup\u003e noted that smoking history has been included as a risk factor for radiodermatitis, as smoking aggravates the microcirculation abnormality that caused by radiotherapy. Due to the low proportion of smoking history in the enrolled patients in this study, they were not included in the study scope. Further relevant studies are needed to determine whether metabolic abnormalities such as obesity and diabetes that affect the repair mechanism of radiological damage to the skin.\u003c/p\u003e\n\n\u003ch2\u003eAdjuvant radiotherapy\u003c/h2\u003e\n\u003cp\u003eAdjuvant radiotherapy after breast conserving radical surgery can reduce the local recurrence rate of breast cancer, among which patients with high risk factors that need adjuvant chemotherapy to improve their survival rate. Although radiotherapy combined with adjuvant chemotherapy can exacerbate adverse reactions, but generally for most patients with good tolerability, postoperative radiotherapy and adjuvant chemotherapy are safe and feasible. Radiotherapy combined with adjuvant chemotherapy also demonstrated improved rates of breast conservation and reduced risk of locoregional recurrence, which are safe and feasible \u003csup\u003e[16]\u003c/sup\u003e. In this study, the factor of concurrent chemotherapy was taken into consideration to analyze whether it aggravates the incidence of radiodermatitis.\u003c/p\u003e\n\n\u003ch2\u003ePatient age ≤ 40 years\u003c/h2\u003e\n\u003cp\u003eAge ≤ 40 years for the viewpoint that the prognosis of young women with breast cancer is worse than that of elderly women, relevant western studies define the range of young women as ≤ 40 years, while the Chinese domestic literatures classified the age as ≤ 40 years as well \u003csup\u003e[17–18]\u003c/sup\u003e. In terms of this study, age ≤ 40 years was considered as one of the risk factors for the occurrence of radiodermatitis, and statistical analysis was conducted.\u003c/p\u003e\n\n\u003ch2\u003eSkin color and sun exposure\u003c/h2\u003e\n\u003cp\u003eThe grating characteristics of Chinese women’s skin color were evaluated in this study. The effect of X-ray radiation on the skin during radiotherapy depends on how sensitive the skin towards to the radiation \u003csup\u003e[19]\u003c/sup\u003e. Considering that the principle of the action of rays on the skin is similar to the reaction of the skin caused by solar irradiation, this study suggests that the sunlight reaction can be related to dermatitis reaction of patients. In this study, the skin color of patients was evaluated and the degree of sunlight exposure of patients to their skin color and daily activities were also evaluated. From level 1 (always exposure to the sun, rarely tanned) to level 4 (rarely exposure to the sun, but easily tanned), in order to reflect the sensitivity of the patients to radiation, and thus to infer the possibility of radiodermatitis. According to the study of Yamazaki et al. (2011) \u003csup\u003e[20]\u003c/sup\u003e, skin pigmentation of patients after radiotherapy was predicted by skin color changes that caused by sun exposure; This study believed that the degree of sun exposure and skin color of patients could be used as criteria to judge whether patients were at high risk of radiodermatitis.\u003c/p\u003e\n\n\u003ch2\u003eTreatment time\u003c/h2\u003e\n\u003cp\u003eWhen the treatment time is summer, the climate is hot and humid, the capillary diastole and the blood circulation is rich. Increased sensitivity of vascular endothelia cell to the radiation, coupled with more local skin sweating, thus increase the chance of wet dermatitis. There are few research data and references in this filed. Combined with the experience of a large number of clinical nurses, it is considered that the admission time of patients with radiodermatitis is concentrated in summer. Therefore, the correlation between seasonal factors and the incidence of radiodermatitis was statistically analyzed.\u003c/p\u003e\n\n\u003ch2\u003eLocal thermal therapy\u003c/h2\u003e\n\u003cp\u003eLocal thermal therapy is an advanced and effective method to treat tumor. The clinical trial has shown that the combination of thermal therapy and radiotherapy can significantly improve the local control rate of tumors and the survival rate of patients \u003csup\u003e[21]\u003c/sup\u003e. Lilla et al. (2007) \u003csup\u003e[22]\u003c/sup\u003e reported that the radiotherapy circumstance of 416 cases of breast cancer patients after breast conserving surgery, and analyzed the significant relationship between radioactive dermatitis and telangiectasia, this allowed for local hyperthermia to cause telangiectasia at the site of radiotherapy. At the same time, combined with relevant studies and analysis, it was found that although adverse reactions to thermal therapy were relatively mild, it can still cause blisters, subcutaneous indentation, subcutaneous pain, and even more serious skin damage such as radiodermatitis \u003csup\u003e[23]\u003c/sup\u003e. Therefore, local thermal therapy was included in this study.\u003c/p\u003e\n\n\u003ch2\u003eA hot bath/ scratching the skin/ Wearing a bra/ exposure to the sun\u003c/h2\u003e\n\u003cp\u003eAfter the patients with a diagnosis of breast cancer have had radiotherapy, the skin tissue where has been accepted radiation became thinner than before, particularly prone to skin reactions. Relevant evidence-based nursing studies show that in order to reduce reaction after radiotherapy, relevant skin care measures include: 1) Educating patients to wear cotton underwear to avoid skin friction in and around the radiotherapy area. 2) Local soap scrubbing or hot water bath and sun exposure are prohibited to avoid skin irritation in the radiotherapy area. 3) When the skin in the radiotherapy area is itchy and unbearable, gently pat the local skin with their hand, cannot scratch the skin \u003csup\u003e[24]\u003c/sup\u003e. Although such nursing education is conducted by nurses to patients in daily clinical care, the effects of activities such as hot baths, scratching of skin, wearing of bras and exposure to the sun on radiodermatitis are still discussed and analyzed in consideration of the differences in patient compliance.\u003c/p\u003e"},{"header":"5. Conclusion","content":"\u003cp\u003eThis retrospective study is based on the observation and statistics of the relevant clinical characteristics and incidence of chest wall radiodermatitis of 521 female breast cancer patients treated with radiotherapy after breast conserving surgery. It was found that age ≤ 40 years, fair skin, treatment time is in summer, BMI ≥ 25, local hyperthermia, sun exposure, hot water bath, skin scratching and bra wearing significantly increased the risk of radiodermatitis. Given the impact of radiodermatitis, especially grade 2 to 3 radiodermatitis, on permanent damage to the skin, the nursing team needs to carefully assess the patient’s risk factors before and after radiotherapy, and carry out targeted nursing for high-risk groups, to reduce the incidence of radiodermatitis, improve the quality of life of patients, maintain the beauty of breast after breast-conserving treatment, and reduce the psychological pressure of patients.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cul\u003e\u003cli\u003eEthical approval This study has been approved by the Ethics Committee of Drug Clinical Trials of Huazhong University of Science and Technology; It has been carried out in the city of Wuhan, where located in the middle south of China, with the registration number 1900022422. The participants who have been involved in this study has signed the informed consent form before being included in the study.\u003c/li\u003e\u003cli\u003eConsent for publication Not applicable.\u003c/li\u003e\u003cli\u003eAvailability of data and materials The data be used and analyzed during the current study are available from the corresponding authors on reasonable request.\u003c/li\u003e\u003cli\u003eCompeting interests The authors declare that they have no competing interests.\u003c/li\u003e\u003cli\u003eFunding The role of 2018 textbook construction project of Huazhong University of Science and Technology in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript that gave much support. The reference number is 02.05.18020018.\u003c/li\u003e\u003cli\u003eAuthors contributions\u003c/li\u003e\u003cli\u003ePENG Xin, female, master, supervisor nurse, head nurse, Hubei anti-cancer association breast cancer professional committee vice chairman, teacher of Nursing Department of Tongji Medical College, Hubei province pain demonstration ward evaluation expert, Chinese journal of nursing manuscript reviewer; Department of Breast Oncology, Wuhan Union Medical College Hospital, Wuhan, China. Email: [email protected], Mobile phone: 15071399933, ORCID number: 0000 0002 8061 2335. She initiated and conceived this research article with her nursing team, and collect data from the ward of breast cancer oncology. She also did supervision, suggestion and involved in the original article writing.\u003c/li\u003e\u003cli\u003eCo-first author - REN Yi, female, Chinese registered nurse; former registered nurse of Department of integrated Chinese and western medicine, Wuhan Union Medical College Hospital, Wuhan, China; Currently as a Senior nursing student in Wintec institute of science and technology, Hamilton, New Zealand. Email: [email protected], Mobile phone: 022 6852603, ORCID number: 0000 0003 0872 9915. She cooperated with the nursing team, help them with problem solving and given advice with the article. She also involved in translating the Chinese version to English version, and find relevant resources to support the project.\u003c/li\u003e\u003c/ul\u003e\n\u003ch3\u003eCorresponding author:\u003c/h3\u003e\n\u003cul\u003e\u003cli\u003eHE Qin, female, master, head nurse, teacher of Nursing Department of Tongji Medical College, Hubei province pain demonstration ward evaluation expert; Public Health Department, Wuhan Union Medical College Hospital, Wuhan. Email: \u003ca href=\"mailto:[email protected]\"\u003e\u003ca href=\"http://[email protected]\"\[email protected]\u003c/a\u003e\u003c/a\u003e. She has been involved in the clinical supervision and the article review.\u003c/li\u003e\u003cli\u003eXIONG Lijuan, female, master, supervisor nurse, head nurse, teacher of Nursing Department of Tongji Medical College, Hubei province pain demonstration ward evaluation expert, Chinese journal of nursing manuscript reviewer; Nursing Department, Wuhan Union Medical College Hospital, Wuhan. Email: [email protected]. She has been involved in the clinical supervision and the article review.\u003c/li\u003e\u003c/ul\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eSecginli S, Nahcivan N O, Gunes G, et al. Interventions promoting breast cancer screening among Turkish women with global implications: a systematic review[J]. Worldviews on Evidence‐Based Nursing, 2017, 14(4): 316-323.\u003c/li\u003e\n\u003cli\u003eTang Y, Mao W, Tang S. Primary and secondary prevention of breast cancer in China: a scoping review[J]. The Lancet, 2019, 394: S76.\u003c/li\u003e\n\u003cli\u003eAlexopoulou E, Katsila T, Tolia M, et al. An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients[J]. Anticancer research, 2018, 38(3): 1615-1622.\u003c/li\u003e\n\u003cli\u003eKole A J, Kole L, Moran M S. Acute radiation dermatitis in breast cancer patients: challenges and solutions[J]. Breast Cancer: Targets and Therapy, 2017, 9: 313.\u003c/li\u003e\n\u003cli\u003eZhang J. 235P Study on the socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women breast cancer[J]. Annals of Oncology, 2019, 30(Supplement_5): mdz240. 059.\u003c/li\u003e\n\u003cli\u003eYao R, Pan B, Xu Y, et al. Abstract P2-14-30: Survival outcomes of breast conserving surgery versus mastectomy for ultrasound detected non-palpable breast cancer in hospital-based screening among Chinese women[J]. 2019.\u003c/li\u003e\n\u003cli\u003eChollet-Hinton L, Anders C K, Tse C K, et al. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study[J]. Breast Cancer Research, 2016, 18(1): 79.\u003c/li\u003e\n\u003cli\u003eRobijns J, Laubach H J. Acute and chronic radiodermatitis: clinical signs, pathophysiology, risk factors and management options[J]. Journal of the Egyptian Women's Dermatologic Society, 2018, 15(1): 2-9.\u003c/li\u003e\n\u003cli\u003ePignol J P, Truong P, Rakovitch E, et al. Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial[J]. Radiotherapy and oncology, 2016, 121(3): 414-419.\u003c/li\u003e\n\u003cli\u003eKitajima M, Mikami K, Noto Y, et al. Quantitative assessment of radiodermatitis through a non‑invasive objective procedure in patients with breast cancer[J]. Molecular and Clinical Oncology, 2019, 12(1): 89-93.\u003c/li\u003e\n\u003cli\u003eLacny S, Wilson T, Clement F, et al. Kaplan\u0026ndash;Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis[J]. Journal of clinical epidemiology, 2018, 93: 25-35.\u003c/li\u003e\n\u003cli\u003eKarbasforooshan H, Hosseini S, Elyasi S, et al. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double‐blind, placebo‐controlled clinical trial[J]. Phytotherapy research, 2019, 33(2): 379-386.\u003c/li\u003e\n\u003cli\u003eBorm K J, Loos M, Oechsner M, et al. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer-the impact of dose distribution and patient related factors[J]. Radiation Oncology, 2018, 13(1): 218.\u003c/li\u003e\n\u003cli\u003eBeamer L C. Novel measurements for radiodermatitis research and clinical care: a pilot and feasibility study[J]. European Journal of Oncology Nursing, 2019, 39: 62-69.\u003c/li\u003e\n\u003cli\u003eMarinello E, Causin F, Brumana M B, et al. Radiodermatitis after spinal arteriovenous fistula embolisation[J]. BMJ case reports, 2016, 2016: bcr2016214384.\u003c/li\u003e\n\u003cli\u003eGarg A K, Buchholz T A. Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer[J]. Annals of surgical oncology, 2015, 22(5): 1434-1440.\u003c/li\u003e\n\u003cli\u003eColes C E, Griffin C L, Kirby A M, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicenter, randomized, controlled, phase 3, non-inferiority trial[J]. The Lancet, 2017, 390(10099): 1048-1060.\u003c/li\u003e\n\u003cli\u003eLiem G S, Mo F K F, Pang E, et al. Chemotherapy-related amenorrhea and menopause in young Chinese breast cancer patients: analysis on incidence, risk factors and serum hormone profiles[J]. PloS one, 2015, 10(10): e0140842.\u003c/li\u003e\n\u003cli\u003eWolf J R, Ling M. Radiation dermatitis [J]. Web link:\u0026nbsp;\u003ca href=\"https://www.uptodate.com/contents/radiation-dermatitis\"\u003ehttps://www.uptodate.com/contents/radiation-dermatitis\u003c/a\u003e , 2018, 11060596.\u003c/li\u003e\n\u003c/ol\u003e\n\u003col start=\"21\"\u003e\n\u003cli\u003eSamanta S, Rice S R, Siddiqui O M, et al. Concurrent External Thermal Therapy and Pencil Beam Scanning Proton Therapy or Photon/Electron Therapy for Recurrent Breast Cancer: Early Outcomes and Toxicity[J]. International Journal of Radiation Oncology\u0026bull; Biology\u0026bull; Physics, 2019, 105(1): E45-E46.\u003c/li\u003e\n\u003cli\u003eAbadeer N S, Murphy C J. Recent progress in cancer thermal therapy using gold nanoparticles[J]. The Journal of Physical Chemistry C, 2016, 120(9): 4691-4716.\u003c/li\u003e\n\u003cli\u003eBeamer L C, Grant M. Using the Dermatology Life Quality Index to Assess How Breast Radiodermatitis Affects Patients\u0026rsquo; Quality of Life[J]. Breast cancer: basic and clinical research, 2019, 13: 1178223419835547.\u003c/li\u003e\n\u003c/ol\u003e"},{"header":"Tables","content":"\u003cp\u003eTable 1 The difference comparison between the two groups of influencing factors [n (%)]\u003c/p\u003e\n\u003cdiv align=\"center\"\u003e\n \u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"510\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"2\"\u003e\n \u003cp\u003efactors\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eNon-radiodermatitis group (n=464)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eDermatitis group\u003c/p\u003e\n \u003cp\u003e(n=57)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u003cem\u003ex\u003c/em\u003e\u003csup\u003e2\u003c/sup\u003e/Z\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eP\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e8.994\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.003\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eAge\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e≤40\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e228(49.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e40(70.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026gt;40\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e236(50.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e17(29.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eHypertension\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.204\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.651\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003enone\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e459(98.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e56(98.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e5(1.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1(1.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eDiabetes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.109\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.741\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003enone\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e444(95.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e54(94.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e20(4.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e3(5.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eBMI(Kg/m\u003csup\u003e2\u003c/sup\u003e)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e8.649\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.003\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026lt;25\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e89(19.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e2(3.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e≥25\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e375(80.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e55(96.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eT stage\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.040\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.842\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003estage1-2\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e275(59.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e33(57.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003estage3-4\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e189(40.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e24(42.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eGrade\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e-0.209\u003csup\u003e△\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.834\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eGrade 1\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e30(6.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e4(7.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eGrade 2\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e382(82.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e47(82.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eGrade 3\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e52(11.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6(10.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eOccurrence time\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e-0.347\u003csup\u003e△\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.729\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026lt;2weeks\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e259(55.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e31(54.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e2-4week\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e145(31.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e17(29.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026gt;4周\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e60(12.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e9(15.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eAdjuvant chemotherapy\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.104\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.747\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eno\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e47(10.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e5(8.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e417(89.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e52(91.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSkin type\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e-3.928\u003csup\u003e△\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.01\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eI\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e13(2.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e12(21.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eII\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e241(51.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e31(54.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eIII\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e176(37.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e10(17.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eIV\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e27(5.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e3(5.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eV\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e7(1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1(1.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSeason\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e13.08\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.004\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eSpring\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e92(19.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e11(19.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eSummer\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e147(31.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e31(54.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eAutumn\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e150(32.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e10(17.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eWinter\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e75(16.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e5(8.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eLocal thermal-therapy\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e9.788\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.002\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eno\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e232(50.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e16(28.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e232(50.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e41(71.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSun exposure\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e9.250\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.002\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eno\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e420(90.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e44(77.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e44(9.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e13(22.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003eSkin scratching\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e11.25\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eno\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e438(94.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e47(82.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e26(5.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e10(17.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eBra dressing\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e10.68\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eno\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e418(90.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e43(75.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e46(9.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e14(24.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eAkimbo the affected limb in the day time\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e4.182\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.041\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eno\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e382(82.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e53(93.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e82(17.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e4(7.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eRaise the affected limb while sleeping\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6.218\u003csup\u003e※\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.013\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eno\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e346(74.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e51(89.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eyes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e118(25.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6(10.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cbr\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n \u003c/table\u003e\n\u003c/div\u003e\n\u003cp\u003e\u0026nbsp; \u0026nbsp;Note: \u003csup\u003e※\u003c/sup\u003eThe statistic x\u003csup\u003e2\u003c/sup\u003e value of the chi-square test，\u003csup\u003e△\u003c/sup\u003eThe statistic Z value of the rank sum test.\u003c/p\u003e\n\u003cp\u003eTable 2 The evaluation of variables\u003c/p\u003e\n\u003cdiv align=\"center\"\u003e\n \u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"2\"\u003e\n \u003cp\u003eVariable\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eValue assignment\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eDependent variable\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eRadiodermatitis\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd rowspan=\"10\"\u003e\n \u003cp\u003eIndependent variable\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003eAge (year)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1=≤40；2=\u0026gt;40\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eBMI\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1=\u0026lt;25Kg/m\u003csup\u003e2\u003c/sup\u003e；2=≥25Kg/m\u003csup\u003e2\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSkin type\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1= type I；2= type II；3= type III；4= type IV；5= type V\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSummer\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003eLocal thermal therapy\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSun exposure\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSkin scratching\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eBra dressing\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eAkimbo of the affected limb in the daytime\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eElevation of the affected limb while sleeping\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0=no；1=yes\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n \u003c/table\u003e\n\u003c/div\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTable 3 Logistic regression analysis of the influence of different factors on radiodermatitis\u003c/p\u003e\n\u003cdiv align=\"center\"\u003e\n \u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"510\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd rowspan=\"2\"\u003e\n \u003cp\u003eFactors\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd rowspan=\"2\"\u003e\n \u003cp\u003eRegression coefficient\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd rowspan=\"2\"\u003e\n \u003cp\u003eStandard error\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd rowspan=\"2\"\u003e\n \u003cp\u003eWald\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd rowspan=\"2\"\u003e\n \u003cp\u003eP\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd rowspan=\"2\"\u003e\n \u003cp\u003eOR\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\"\u003e\n \u003cp\u003e95CI\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"50%\"\u003e\n \u003cp\u003eLower limit\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"50%\"\u003e\n \u003cp\u003eUpper limit\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eage\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e-0.730\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.332\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e4.826\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.028\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.482\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.251\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.924\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eBMI\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.838\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.749\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6.017\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.014\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6.281\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.447\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e27.273\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSkin type\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e-0.728\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.249\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e8.565\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.003\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.483\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.297\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.786\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSummer\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.019\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.323\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e9.973\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.002\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e2.772\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.472\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e5.218\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eLocal thermal therapy\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.973\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.341\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e8.145\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.004\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e2.645\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.356\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e5.158\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSun exposure\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.022\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.414\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6.077\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.014\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e2.778\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.233\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6.259\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eSkin scratching\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.962\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.469\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e4.210\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.040\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e2.618\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.044\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e6.566\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eBra dressing\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.144\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.418\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e7.481\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.006\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e3.140\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e1.383\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e7.128\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eAkimbo the affected limb in the daytime\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e-1.292\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.580\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e4.963\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.026\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.275\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.088\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.856\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\n \u003cp\u003eElevating the affected limb while sleeping\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e-0.998\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.484\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e4.241\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.039\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.369\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.143\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd\u003e\n \u003cp\u003e0.953\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n \u003c/table\u003e\n\u003c/div\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Breast cancer, post-breast-conserving surgery, radiotherapy, risk factors of radio-dermatitis (RD)","lastPublishedDoi":"10.21203/rs.3.rs-15417/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-15417/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eBackground \u003c/p\u003e\u003cp\u003eThe morbidity of breast cancer has been ranked first among female cancers worldwide and increased by 2% each year in these ten years [1]. Although China as a country with a relatively low incidence of breast cancer compares to other countries, the rapid growth rate of breast cancer is still worth noticing [2]. \u003c/p\u003e\u003cp\u003eMethod \u003c/p\u003e\u003cp\u003eA total of 521 patients with breast cancer diagnosed in the Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology and underwent breast conserving surgery (lumpectomy plus local radiotherapy) were selected, to investigate demographic data, disease data, treatment data and behavior data. Using univariate and multivariate logistic regression method to analyze the risk factors of RD after radiotherapy. \u003c/p\u003e\u003cp\u003eResults \u003c/p\u003e\u003cp\u003eThe variable factors of age ≤40 years old, whiter skin, treatment time in summer, BMI≥25, local thermal therapy, sun exposure, skin scratching and bra wearing are the risk factors of radio-dermatitis, while the affected limb akimbo in daytime and elevating the affected limb in sleep are the protective factors of radio-dermatitis. \u003c/p\u003e\u003cp\u003eConclusion \u003c/p\u003e\u003cp\u003eThis study aims to observe the situation of post-radiotherapy RD after breast-conserving surgery in patients with breast cancer, analyze the risk factors related to patients and treatment, and provide the relevant clinical basis for reducing and preventing the occurrence of RD after breast-conserving surgery.\u003c/p\u003e","manuscriptTitle":"Evaluation of the risk factors of radio-dermatitis after breast-conserving surgery","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2020-02-28 22:29:00","doi":"10.21203/rs.3.rs-15417/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"4d391cfa-02b4-4e71-a6ea-3c9084ea81cc","owner":[],"postedDate":"February 28th, 2020","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":63922,"name":"Cancer Biology"},{"id":63923,"name":"Oncology"}],"tags":[],"updatedAt":"","versionOfRecord":[],"versionCreatedAt":"2020-02-28 22:29:00","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-15417","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-15417","identity":"rs-15417","version":["v1"]},"buildId":"WrCJVZZCHTDjtuVLN7oU0","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}